Antibody measurement (procedure)
|
group |
|
Laboratory Procedure
|
5
|
8
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Heart Function Tests
|
phenotype |
|
Diagnostic Procedure
|
17
|
27
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
QRS complex feature
|
phenotype |
|
Finding
|
41
|
69
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Verrucous carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
49
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Premature ventricular contractions
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
56
|
13
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Squamous cell carcinoma of vulva
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
57
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Epithelial hyperplasia of skin
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
79
|
4
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2008 |
Creatinine measurement, serum (procedure)
|
phenotype |
|
Laboratory Procedure
|
124
|
243
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Adult Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
154
|
19
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Childhood Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
154
|
19
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Persistent atrial fibrillation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
156
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
familial atrial fibrillation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
157
|
1
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
phenotype |
|
Finding
|
165
|
368
|
0.100 |
None |
1.000 |
2 |
1
|
2015 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
166
|
374
|
0.100 |
None |
1.000 |
2 |
1
|
2015 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
disease |
|
Finding
|
166
|
370
|
0.100 |
None |
1.000 |
2 |
1
|
2015 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
disease |
|
Finding
|
166
|
373
|
0.100 |
None |
1.000 |
2 |
1
|
2015 |
2019 |
Malignant neoplasm of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
173
|
375
|
0.100 |
None |
1.000 |
2 |
1
|
2015 |
2019 |
Central Nervous System Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
180
|
72
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Hyperuricemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
196
|
76
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Birth Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
214
|
369
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Paroxysmal atrial fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
226
|
8
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Mean Corpuscular Volume (result)
|
phenotype |
|
Laboratory or Test Result
|
269
|
549
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Well Differentiated Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
270
|
22
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
282
|
21
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |